E. Verdun

1.4k total citations
25 papers, 1.1k citations indexed

About

E. Verdun is a scholar working on Pathology and Forensic Medicine, Rheumatology and Oncology. According to data from OpenAlex, E. Verdun has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 11 papers in Rheumatology and 8 papers in Oncology. Recurrent topics in E. Verdun's work include Multiple Sclerosis Research Studies (22 papers), Systemic Lupus Erythematosus Research (10 papers) and Peripheral Neuropathies and Disorders (6 papers). E. Verdun is often cited by papers focused on Multiple Sclerosis Research Studies (22 papers), Systemic Lupus Erythematosus Research (10 papers) and Peripheral Neuropathies and Disorders (6 papers). E. Verdun collaborates with scholars based in Italy, Switzerland and United States. E. Verdun's co-authors include Luca Durelli, Angelo Ghezzi, Pierangelo Barbero, Mauro Zaffaroni, Mauro Bergui, Elisabetta Versino, Enrico Montanari, Alessandra Oggero, Bruno Ferrero and B. Bergamasco and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

E. Verdun

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Verdun Italy 14 843 437 379 259 148 25 1.1k
Benjamin Turner United Kingdom 14 687 0.8× 298 0.7× 195 0.5× 239 0.9× 87 0.6× 42 933
Virginia Devonshire Canada 14 1.0k 1.2× 311 0.7× 306 0.8× 262 1.0× 123 0.8× 35 1.2k
P. O’Connor Canada 10 783 0.9× 221 0.5× 152 0.4× 242 0.9× 233 1.6× 16 1.0k
Fady Joseph United Kingdom 14 474 0.6× 365 0.8× 309 0.8× 128 0.5× 124 0.8× 23 1.0k
Anthony Hamlett United States 9 953 1.1× 308 0.7× 215 0.6× 411 1.6× 164 1.1× 20 1.2k
Paul O’Connor Canada 11 926 1.1× 329 0.8× 294 0.8× 284 1.1× 220 1.5× 22 1.1k
Liliana Patrucco Argentina 17 687 0.8× 269 0.6× 207 0.5× 98 0.4× 145 1.0× 83 992
Xiaojun You United States 19 647 0.8× 236 0.5× 250 0.7× 216 0.8× 96 0.6× 52 846
Edgar Carnero Contentti Argentina 17 732 0.9× 465 1.1× 214 0.6× 74 0.3× 127 0.9× 91 957
T. Pickersgill United Kingdom 8 582 0.7× 253 0.6× 192 0.5× 141 0.5× 193 1.3× 12 730

Countries citing papers authored by E. Verdun

Since Specialization
Citations

This map shows the geographic impact of E. Verdun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Verdun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Verdun more than expected).

Fields of papers citing papers by E. Verdun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Verdun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Verdun. The network helps show where E. Verdun may publish in the future.

Co-authorship network of co-authors of E. Verdun

This figure shows the co-authorship network connecting the top 25 collaborators of E. Verdun. A scholar is included among the top collaborators of E. Verdun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Verdun. E. Verdun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Capkun, Gorana, Raquel Lahoz, E. Verdun, et al.. (2015). Expanding the use of administrative claims databases in conducting clinical real-world evidence studies in multiple sclerosis. Current Medical Research and Opinion. 31(5). 1029–1039. 25 indexed citations
2.
Capkun-Niggli, Gorana, Raquel Lahoz, E. Verdun, et al.. (2013). Medical and Pharmacy Claims-Based Algorithms for Identifying Relapses in Patients with Multiple Sclerosis. Value in Health. 16(7). A582–A582. 4 indexed citations
3.
Verdun, E., et al.. (2011). A new electronic device for subcutaneous injection of IFN-β-1a. Expert Review of Medical Devices. 8(5). 543–553. 8 indexed citations
4.
5.
Traboulsee, Anthony, Cristina Constantinescu, L Kappos, et al.. (2009). Impact of cumulative dose and time on magnetic resonance imaging and clinical outcomes during long-term treatment with subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis: exploratory analyses. Multiple Sclerosis Journal. 15(9). 126–127. 2 indexed citations
6.
Durelli, Luca, Pierangelo Barbero, Mauro Bergui, et al.. (2008). The OPTimization of Interferon for MS Study: 375 μg interferon beta-1b in suboptimal responders. Journal of Neurology. 255(9). 1315–1323. 12 indexed citations
7.
Durelli, Luca, Pierangelo Barbero, Mauro Bergui, et al.. (2007). MRI activity and neutralising antibody as predictors of response to interferon   treatment in multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 79(6). 646–651. 47 indexed citations
8.
Barbero, Pierangelo, E. Verdun, Mauro Bergui, et al.. (2004). High-dose, frequently administered interferon beta therapy for relapsing–remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction study. Journal of the Neurological Sciences. 222(1-2). 13–19. 24 indexed citations
9.
Solaro, Claudio, Giampaolo Brichetto, Maria Pia Amato, et al.. (2004). The prevalence of pain in multiple sclerosis. Neurology. 63(5). 919–921. 199 indexed citations
10.
Durelli, Luca, et al.. (2003). Immunoglobulin treatment of multiple sclerosis: future prospects. Neurological Sciences. 24(0). s234–s238. 3 indexed citations
11.
Verdun, E., G. Isoardo, Alessandra Oggero, et al.. (2002). Autoantibodies in Multiple Sclerosis Patients Before and During IFN- β 1b Treatment: Are They Correlated with the Occurrence of Autoimmune Diseases?. Journal of Interferon & Cytokine Research. 22(2). 245–255. 27 indexed citations
12.
Barbero, Pierangelo, E. Verdun, Mauro Bergui, et al.. (2002). Is it possible to reduce the dose of interferon (IFN) beta in MS patients with a prolonged MRI-confirmed absence of disease activity?. 58. 1 indexed citations
13.
Durelli, Luca, Alessandra Oggero, E. Verdun, et al.. (2001). Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study. Journal of the Neurological Sciences. 193(1). 17–22. 25 indexed citations
14.
Durelli, Luca, Alessandra Oggero, E. Verdun, et al.. (2001). Interferon-β dose and efficacy: the OPTIMS study. Neurological Sciences. 22(2). 201–203. 13 indexed citations
15.
Isoardo, G., Bruno Ferrero, Pierangelo Barbero, et al.. (2001). Anti-GM1 and anti-sulfatide antibodies in polyneuropathies
Threshold titers and accuracy. Acta Neurologica Scandinavica. 103(3). 180–187. 12 indexed citations
16.
Durelli, Luca, Bruno Ferrero, Alessandra Oggero, et al.. (2001). Thyroid Function and Autoimmunity during Interferon β-1b Treatment: A Multicenter Prospective Study. The Journal of Clinical Endocrinology & Metabolism. 86(8). 3525–3532. 39 indexed citations
17.
Durelli, Luca, Bruno Ferrero, Alessandra Oggero, et al.. (2001). Liver and thyroid function and autoimmunity during interferon-β1b treatment for MS. Neurology. 57(8). 1363–1370. 49 indexed citations
18.
Durelli, Luca, Bruno Ferrero, Alessandra Oggero, et al.. (1999). Autoimmune events during interferon beta-1b treatment for multiple sclerosis. Journal of the Neurological Sciences. 162(1). 74–83. 68 indexed citations
19.
Bongioanni, Maria Roberta, Luca Durelli, Bruno Ferrero, et al.. (1996). Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosis. Journal of the Neurological Sciences. 143(1-2). 91–99. 15 indexed citations
20.
Durelli, Luca, Maria Roberta Bongioanni, Rossana Cavallo, et al.. (1995). Interferon alpha treatment of relapsing–remitting multiple sclerosis: long-term study of the correlations between clinical and magnetic resonance imaging results and effects on the immune function. Multiple Sclerosis Journal. 1(1_suppl). S32–S37. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Turner Breakdown of academic impact, for papers by Virginia Devonshire Breakdown of academic impact, for papers by P. O’Connor Breakdown of academic impact, for papers by Fady Joseph Breakdown of academic impact, for papers by Anthony Hamlett Breakdown of academic impact, for papers by Paul O’Connor Breakdown of academic impact, for papers by Liliana Patrucco Breakdown of academic impact, for papers by Xiaojun You Breakdown of academic impact, for papers by Edgar Carnero Contentti Breakdown of academic impact, for papers by T. Pickersgill
Rankless by CCL
2026